634 Production and testing of a novel bispecific nanobody construct targeting NK cells and EGFR expressing malignancies

• Henk Verheul,
• Tanja de Gruijl,
• Elisa Toffoli,
• Abdolkarim Sheikhi,
• Roeland Lameris,
• Lisa King,
• Jurriaan Tuynman,
• Jan Spanholtz,
• Hans Van der Vliet

Affiliations

Henk Verheul

Aff1 grid.16872.3a000000040435165XDepartment of Medical OncologyVU University Medical Center, Amsterdam Amsterdam Netherlands

Tanja de Gruijl

1Amsterdam University Medical centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands

Elisa Toffoli

Amsterdam UMC, Amsterdam, Netherlands

Abdolkarim Sheikhi

Amsterdam UMC, Amsterdam, Netherlands

Roeland Lameris

Amsterdam UMC, Amsterdam, Netherlands

Lisa King

Amsterdam UMC, Amsterdam, Netherlands

Jurriaan Tuynman

Amsterdam UMC, Amsterdam, Netherlands

Jan Spanholtz

Amsterdam UMC, Amsterdam, Netherlands

Hans Van der Vliet

Amsterdam UMC, Amsterdam, Netherlands